Image Credit :https://www.psychiatryadvisor.com/home/bipolar-disorder-advisor/presence-of-psychosis-in-bipolar-depression-not-a-factor-in-treatment-outcomes/
Schizophrenia is associated with risk factors for poor outcomes with SARS-CoV-2/coronavirus disease 2019 (COVID-19) infection, including diabetes, hypertension, and chronic obstructive pulmonary disease (COPD). A recent study found that schizophrenia was associated with an increased risk of severe COVID-19 infection. Whether health outcomes and care differ between patients with COVID-19 with (versus without) comorbid schizophrenia remains unclear. Fond and colleagues2 compared in-hospital mortality and intensive care unit (ICU) admissions between patients with schizophrenia and those without a diagnosis of severe mental illness in a French population-based cohort study.
People with severe mental illness (SMI) are a vulnerable population. In the context of COVID-19, there is reason to suspect they may be at increased risk of contracting SARS-CoV-2 and have worse outcomes following infection, however we found no existing data that quantified these risks. Public health measures associated with COVID-19, including quarantine of suspected cases and lockdowns may negatively affect the mental health status of people with SMI, through change of environment, disruption of services, increased stress and isolation. Existing research points to greater psychological distress during the pandemic for people with SMI, rather than demonstrating this distress is due to the pandemic. The authors concluded that this is the largest series of patients with schizophrenia and COVID-19 to date. They found evidence for the existence of disparities in health and health care between patients with versus without schizophrenia, including increased in-hospital mortality and decreased ICU admission. Study limitations include the absence of data on the time between onset of infection and hospitalization, psychotropic medication, and the use of anti-COVID-19 treatments. Nevertheless, findings suggest the importance of health care strategies before, during, and after hospitalization for reducing health disparities in this vulnerable population
Normally, younger patients with schizophrenia who smoke, are obese, and have COPD are at heightened risk for poor outcomes with COVID-19 infection and should be targeted for early intervention.
Schizophrenia has become a serious matter in our society. As per the above stats, it is very clear that what type of risk factors can occur in a person’s life suffering from schizophrenia. There are treatment centers in Asia but not all specialize in treating it effectively.
There are few treatment centers present in Malaysia; among the few one of them is “Serene Retreat”. Serene Retreat’s treatment philosophy focuses on holistic change through the incorporation of a scientific approach with detailed attention to the recovery by helping the clients to strengthen six core aspects of the Self Thought, Emotional, Physical, Spiritual, Social and Cultural.
We have got our treatment centers across Malaysia so you can reach us via CALL OR WHATSAPP +6014-903 6413 Or
Visit our website www.sereneretreat.com.my.
11, Jalan Setiakasih 9, Bukit Damansara, 50490 Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur